Synopsis of the national institute for health and clinical excellence guideline for management of transient loss of consciousness

Annals of Internal Medicine

Volumn 155, Issue 8, 2011, Pages 543-550

  Cooper, Paul N ^a   Westby, Maggie ^b   Pitcher, David W ^c   Bullock, Ian ^b  

^a Greater Manchester Neurosciences Centre   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTID SINUS SYNDROME; ELECTROCARDIOGRAPHY; EPILEPSY; HEART ARRHYTHMIA; HEART DISEASE; HOLTER MONITORING; HUMAN; ORTHOSTATIC HYPOTENSION; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYNCOPE; TRANSIENT LOSS OF CONSCIOUSNESS; UNCONSCIOUSNESS;

EID: 80054767993     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-8-201110180-00368     Document Type: Review

References (29)

1. Fitzpatrick AP, Cooper P. Diagnosis and management of patients with blackouts. Heart. 2006;92:559-68.
2. Patient Stories: Misdiagnosis. Stratford-upon-Avon, United Kingdom: Syncope Trust and Reflex Anoxic Seizures; 2011. Accessed at www.stars.org.uk/patient-stories/misdiagnosis on 9 August 2011.
3. Westby M, Davis S, Bullock I, Miller P, Cooper PN, Turnbull N, et al. Transient Loss of Consciousness ("Blackouts") Management in Adults and Young People. London: National Institute for Health and Clinical Excellence; 2010. Accessed at http://guidance.nice.org.uk/CG109 on 9 August 2011.
4. Hill J, Bullock I, Alderson P. A summary of the methods that the National Clinical Guideline Centre uses to produce clinical guidelines for the National Institute for Health and Clinical Excellence. Ann Intern Med. 2011;154:752-7.
5. National Institute for Health and Clinical Excellence. The Guidelines Manual. London: National Institute for Health and Clinical Excellence; 2009. Accessed at www.nice.org.uk/aboutnice/howwework/developingniceclinicalguidelines/clinicalguidelinedevelopmentmethods/clinical_guideline_development_methods.jsp on 9 August 2011.
6. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
7. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
8. Rockx MA, Hoch JS, Klein GJ, Yee R, Skanes AC, Gula LJ, et al. Is ambulatory monitoring for "community-acquired" syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J. 2005;150:1065.
9. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol. 1997;79: 207-8.
10. Linzer M, Pritchett EL, Pontinen M, McCarthy E, Divine GW. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol. 1990;66:214-9.
11. Schuchert A, Maas R, Kretzschmar C, Behrens G, Kratzmann I, Meinertz T. Diagnostic yield of external electrocardiographic loop recorders in patients with recurrent syncope and negative tilt table test. Pacing Clin Electrophysiol.2003;26:1837-40.
12. Boersma L, Mont L, Sionis A, García E, Brugada J. Value of the implantable loop recorder for the management of patients with unexplained syncope. Europace.2004;6:70-6.
13. Brignole M, Menozzi C, Maggi R, Solano A, Donateo P, Bottoni N, et al. The usage and diagnostic yield of the implantable loop-recorder in detection of the mechanism of syncope and in guiding effective antiarrhythmic therapy in older people. Europace. 2005;7:273-9.
14. Donateo P, Brignole M, Menozzi C, Bottoni N, Alboni P, Dinelli M, et al. Mechanism of syncope in patients with positive adenosine triphosphate tests. J Am Coll Cardiol. 2003;41:93-8.
15. Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J. 2006;27:351-6.
16. Krahn AD, Klein GJ, Yee R, Norris C. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol. 1998;82:117-9.
17. Krahn AD, Klein GJ, Yee R, Skanes AC; REVEAL Investigators. Predictive value of presyncope in patients monitored for assessment of syncope. Am Heart J.2001;141:817-21.
18. Krahn AD, Klein GJ, Fitzpatrick A, Seidl K, Zaidi A, Skanes A, et al. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing Clin Electrophysiol. 2002;25:37-41.
19. Krahn AD, Klein GJ, Yee R, Skanes AC. Detection of asymptomatic arrhythmias in unexplained syncope. Am Heart J. 2004;148:326-32.
20. Lombardi F, Calosso E, Mascioli G, Marangoni E, Donato A, Rossi S, et al. Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope. Europace. 2005;7:19-24.
21. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L, et al; International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104:1261-7.
22. Nierop PR, van Mechelen R, van Elsäcker A, Luijten RH, Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin Electrophysiol. 2000;23:1532-8.
23. Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease. Heart. 2008;94:e17.
24. Pierre B, Fauchier L, Breard G, Marie O, Poret P, Babuty D. Implantable loop recorder for recurrent syncope: influence of cardiac conduction abnormalities showing up on resting electrocardiogram and of underlying cardiac disease on follow-up developments. Europace. 2008;10:477-81.
25. Seidl K, Drögemüller A, Rameken M, Zahn R, Schneider S, Senges J. Usefulness of a non-invasive scoring system in predicting the outcome of electrophysiologic studies in non-invasively unexplained syncope. Z Kardiol. 2003;92: 147-54.
26. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence; 2008. Accessed at www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008. pdf.
27. National Institute for Health and Clinical Excellence. Transient Loss of Consciousness in Adults: Stakeholder Lists and How to Register. London: National Institute for Health and Clinical Excellence; 2010. Accessed at http://guidance.nice.org.uk/CG/Wave16/81/SHregistration on 9 August 2011.
28. National Collaborating Centre for Primary Care. The Epilepsies: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care. London: Royal College of General Practitioners; 2004. Accessed at http://guidance.nice.org.uk/CG20 on 9 August 2011.
29. Parry SW, Reeve P, Lawson J, Shaw FE, Davison J, Norton M, et al. The Newcastle protocols 2008: an update on head-up tilt table testing and the management of vasovagal syncope and related disorders. Heart. 2009;95:416-20.